Work

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.8505

Authors: Jeffrey A Bogart, Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles S. Kuzma, John Heymach, William J. Petty, Laurie E. Gaspar, Saiama Naheed Waqar, Tom Stinchcombe, Jeffrey D. Bradley, Everett E. Vokes

Institutions: SUNY Upstate Medical University, Duke University, Duke Cancer Institute, Duke University Health System, The University of Texas MD Anderson Cancer Center, FirstHealth of the Carolinas, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, University of Colorado Cancer Center, Washington University in St. Louis, University of Chicago

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3166170782

Cites:

Cited by: 37

Related to: 10